The burgeoning field of peptide-based therapeutics necessitates innovative strategies for the design and delivery of these potent biomolecules. Optimizing peptides to specifically target disease while ensuring efficient administration to target sites remains a considerable challenge. Experts are continuously developing novel approaches to mitigate